Your browser doesn't support javascript.
loading
A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis.
Miyabe, Chie; Miyabe, Yoshishige; Komiya, Takaki; Shioya, Hiroki; Miura, Noriko N; Takahashi, Kei; Ohno, Naohito; Tsuboi, Ryoji; Luster, Andrew D; Kawai, Shinichi; Miyasaka, Nobuyuki; Nanki, Toshihiro.
Afiliación
  • Miyabe C; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Miyabe Y; Department of Dermatology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
  • Komiya T; Center for Immunology and Inflammatory Disease, Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, CNY149-8 13th St, Boston, MA, 02129, USA.
  • Shioya H; Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
  • Miura NN; Center for Immunology and Inflammatory Disease, Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, CNY149-8 13th St, Boston, MA, 02129, USA.
  • Takahashi K; Department of Biology and Pharmacology, Ono Pharmaceutical Co. Ltd, 3-1-1, Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan.
  • Ohno N; Department of Biology and Pharmacology, Ono Pharmaceutical Co. Ltd, 3-1-1, Sakurai, Shimamoto-cho, Mishima-gun, Osaka, 618-8585, Japan.
  • Tsuboi R; Department of Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science School of Pharmacy, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
  • Luster AD; Department of Pathology, Toho University, 2-17-6 Ohashi, Meguro, Tokyo, 153-8515, Japan.
  • Kawai S; Department of Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science School of Pharmacy, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
  • Miyasaka N; Department of Dermatology, Tokyo Medical University, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
  • Nanki T; Center for Immunology and Inflammatory Disease, Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, CNY149-8 13th St, Boston, MA, 02129, USA.
Inflamm Res ; 66(4): 335-340, 2017 Apr.
Article en En | MEDLINE | ID: mdl-27942751
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Asunto principal: Esfingosina / Vasculitis / Lisofosfolípidos / Receptores de Lisoesfingolípidos Tipo de estudio: Prognostic_studies Idioma: En Revista: Inflamm Res Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Asunto principal: Esfingosina / Vasculitis / Lisofosfolípidos / Receptores de Lisoesfingolípidos Tipo de estudio: Prognostic_studies Idioma: En Revista: Inflamm Res Año: 2017 Tipo del documento: Article País de afiliación: Japón